1. Home
  2. IVVD vs PMEC Comparison

IVVD vs PMEC Comparison

Compare IVVD & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • PMEC
  • Stock Information
  • Founded
  • IVVD 2020
  • PMEC 1984
  • Country
  • IVVD United States
  • PMEC Singapore
  • Employees
  • IVVD N/A
  • PMEC N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • PMEC
  • Sector
  • IVVD Health Care
  • PMEC
  • Exchange
  • IVVD Nasdaq
  • PMEC Nasdaq
  • Market Cap
  • IVVD 63.4M
  • PMEC 56.9M
  • IPO Year
  • IVVD 2021
  • PMEC 2023
  • Fundamental
  • Price
  • IVVD $1.60
  • PMEC $1.73
  • Analyst Decision
  • IVVD Strong Buy
  • PMEC
  • Analyst Count
  • IVVD 5
  • PMEC 0
  • Target Price
  • IVVD $5.11
  • PMEC N/A
  • AVG Volume (30 Days)
  • IVVD 4.4M
  • PMEC 34.5K
  • Earning Date
  • IVVD 11-13-2025
  • PMEC 01-01-0001
  • Dividend Yield
  • IVVD N/A
  • PMEC N/A
  • EPS Growth
  • IVVD N/A
  • PMEC N/A
  • EPS
  • IVVD N/A
  • PMEC N/A
  • Revenue
  • IVVD $46,210,000.00
  • PMEC $74,349,000.00
  • Revenue This Year
  • IVVD $112.35
  • PMEC N/A
  • Revenue Next Year
  • IVVD $272.14
  • PMEC N/A
  • P/E Ratio
  • IVVD N/A
  • PMEC N/A
  • Revenue Growth
  • IVVD 1941.08
  • PMEC 2.52
  • 52 Week Low
  • IVVD $0.35
  • PMEC $0.54
  • 52 Week High
  • IVVD $2.74
  • PMEC $1.89
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 71.86
  • PMEC 46.48
  • Support Level
  • IVVD $1.15
  • PMEC $1.61
  • Resistance Level
  • IVVD $1.15
  • PMEC $1.80
  • Average True Range (ATR)
  • IVVD 0.12
  • PMEC 0.07
  • MACD
  • IVVD 0.02
  • PMEC -0.02
  • Stochastic Oscillator
  • IVVD 99.85
  • PMEC 44.00

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About PMEC Primech Holdings Ltd.

Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.

Share on Social Networks: